Related Experiment Video
Updated: Feb 25, 2026

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9
Alexander P Hynes1, Geneviève M Rousseau1, Marie-Laurence Lemay1
1Département de biochimie, de microbiologie, et de bioinformatique, Faculté des sciences et de génie, Groupe de recherche en écologie buccale, Faculté de médecine dentaire, Université Laval, Québec City, QC, G1V 0A6, Canada.
Abstract:
The CRISPR-Cas system owes its utility as a genome-editing tool to its origin as a prokaryotic immune system. The first demonstration of its activity against bacterial viruses (phages) is also the first record of phages evading that immunity 1 . This evasion can be due to point mutations 1 , large-scale deletions 2 , DNA modifications 3 , or phage-encoded proteins that interfere with the CRISPR-Cas system, known as anti-CRISPRs (Acrs) 4 . The latter are of biotechnological interest, as Acrs can serve as off switches for CRISPR-based genome editing 5 . Every Acr characterized to date originated from temperate phages, genomic islands, or prophages 4-8 , and shared properties with the first Acr discovered. Here, with a phage-oriented approach, we have identified an unrelated Acr in a virulent phage of Streptococcus thermophilus. In challenging a S. thermophilus strain CRISPR-immunized against a set of virulent phages, we found one that evaded the CRISPR-encoded immunity >40,000× more often than the others. Through systematic cloning of its genes, we identified an Acr solely responsible for the abolished immunity. We extended our findings by demonstrating activity in another S. thermophilus strain, against unrelated phages, and in another bacterial genus immunized using the heterologous SpCas9 system favoured for genome editing. This Acr completely abolishes SpCas9-mediated immunity in our assays.
Insights
Researchers discovered a novel anti-CRISPR (Acr) protein in a virulent phage that effectively disables CRISPR-Cas immunity in bacteria. This finding expands the known diversity of Acrs and offers new tools for controlling genome editing.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- The CRISPR-Cas system, derived from prokaryotic immunity, is a powerful genome-editing tool.
- Bacterial viruses (phages) can evade CRISPR-Cas immunity through various mechanisms, including anti-CRISPR (Acr) proteins.
- Existing Acrs originate from temperate phages or genomic elements and share common properties.
Purpose of the Study:
- To identify novel anti-CRISPR (Acr) proteins from virulent phages.
- To characterize the mechanism and scope of activity of a newly identified Acr.
- To explore the biotechnological potential of Acrs as off-switches for CRISPR-Cas genome editing.
Main Methods:
- Challenged a Streptococcus thermophilus strain with CRISPR immunity against virulent phages.
- Identified a phage exhibiting exceptionally high evasion rates (>40,000×).
- Systematically cloned phage genes to pinpoint the specific Acr responsible for immunity abolition and tested its activity in different strains and bacterial genera using the SpCas9 system.
Main Results:
- A novel, unrelated Acr was identified in a virulent phage infecting Streptococcus thermophilus.
- This Acr was solely responsible for abolishing CRISPR-Cas immunity in the tested strain.
- The Acr demonstrated activity in a different S. thermophilus strain, against unrelated phages, and effectively disabled SpCas9-mediated immunity in another bacterial genus.
Conclusions:
- A new class of anti-CRISPR (Acr) protein has been discovered in a virulent phage, distinct from previously characterized Acrs.
- This Acr represents a significant expansion of the known anti-CRISPR repertoire and their evolutionary origins.
- The identified Acr completely inhibits SpCas9 activity, highlighting its potential as a controllable 'off switch' for CRISPR-based genome editing applications.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
The Antiviral System of Bacteria and Archaea: CRISPR
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

